Blinatumomab Bridging Therapy for BALL
Phase 2
Terminated
- Conditions
- B-cell Acute Lymphoblastic LeukemiaRelapsed B-cell Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2020-09-21
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Michael Burke
- Target Recruit Count
- 2
- Registration Number
- NCT04556084
- Locations
- 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Epigenetic Reprogramming in Relapse AML
Phase 1
Terminated
- Conditions
- Leukemia, Acute Myeloid
- Interventions
- First Posted Date
- 2015-04-09
- Last Posted Date
- 2019-01-24
- Lead Sponsor
- Michael Burke
- Target Recruit Count
- 3
- Registration Number
- NCT02412475
- Locations
- 🇺🇸
Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath